<?xml version="1.0" encoding="UTF-8"?>
<p id="para0013">Tocilizumab (Actemra
 <sup>TM</sup>) is a recombinant humanized monoclonal antibody directed against the IL‚Äê6 receptor. Endogenous IL-6 is induced by inflammatory stimuli and mediates a variety of immunological responses. Inhibition of IL-6 receptors by tocilizumab leads to a reduction in cytokine and acute phase reactant production.
</p>
